Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2017 Filed Aug 4, 2017 19:08 UTC |
Giovanni CiseraniGrpPres-Global F&HC,Baby&Fem
|
GrantRestricted Stock Units · Derivative | 150.286 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-024993 · form4.xml · derivative · entry 2 Giovanni Ciserani · CIK 0001580892 · GrpPres-Global F&HC,Baby&Fem 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,840.501 Underlying: Common Stock · 150.286 shares Expires not disclosed F2 · derivative.exercise_price: Dividend equivalents in the form of Retirement Restricted Stock Units (RSU's) previously awarded pursuant to Issuer's retirement program. All such RSU's represent a contingent right to receive Procter & Gamble common stock or cash settlement. F3 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F3 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 15, 2017 Filed Aug 4, 2017 19:10 UTC |
Bishop Steven DGroup President Global Health
|
GrantRestricted Stock Units · Derivative | 91.096 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-024994 · form4.xml · derivative · entry 4 Bishop Steven D · CIK 0001669212 · Group President Global Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422.889 Underlying: Common Stock · 91.096 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Retirement Restricted Stock Units (RSUs) previously awarded pursuant to Issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock or cash settlement. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 15, 2017 Filed Aug 4, 2017 19:23 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
GrantRestricted Stock Units · Derivative | 55.175 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-024998 · form4.xml · derivative · entry 3 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 766.323 Underlying: Common Stock · 55.175 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 15, 2017 Filed Aug 4, 2017 19:25 UTC |
Fish Kathleen BChief Technology Officer
|
GrantRestricted Stock Units · Derivative | 18.006 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-024999 · form4.xml · derivative · entry 3 Fish Kathleen B · CIK 0001598156 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119.044 Underlying: Common Stock · 18.006 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 15, 2017 Filed Aug 7, 2017 18:51 UTC |
Schomburger Jeffrey KGlobal Sales Officer, CBD
|
GrantRestricted Stock Units · Derivative | 91.235 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-025097 · form4.xml · derivative · entry 3 Schomburger Jeffrey K · CIK 0001630117 · Global Sales Officer, CBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 815.116 Underlying: Common Stock · 91.235 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 04, 2017 Filed May 4, 2017 16:31 UTC |
Louvet PatriceGroup President, Global Beauty
|
SaleCommon Stock | 3,837 | $87.00 | $333,819.00 |
DisclosureSEC source: 0001127602-17-016815 · form4.xml · nonDerivative · entry 1 Louvet Patrice · CIK 0001669213 · Group President, Global Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,913.006 Read SEC document |
| May 01, 2017 Filed May 3, 2017 17:39 UTC |
Bishop Steven DGroup President Global Health
|
GiftCommon Stock | 2,291 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-016518 · form4.xml · nonDerivative · entry 2 Bishop Steven D · CIK 0001669212 · Group President Global Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,607.874 Read SEC document |
| May 01, 2017 Filed May 3, 2017 17:39 UTC |
Bishop Steven DGroup President Global Health
|
SaleCommon Stock | 2,668.1677 | $87.34 | $233,025.23 |
DisclosureSEC source: 0001127602-17-016518 · form4.xml · nonDerivative · entry 1 Bishop Steven D · CIK 0001669212 · Group President Global Health 10b5-1 filing: Not disclosed Ownership: Indirect · By Retirement Plan Trustee Disclosed balance after: 16,622.1379 F1 · balance_after: Reflects adjustment to PST through March 31, 2017. Read SEC document |
| April 03, 2017 Filed Apr 3, 2017 16:49 UTC |
Schomburger Jeffrey KGlobal Sales Officer, CBD
|
Tax withholdingCommon Stock | 508 | $90.09 | $45,763.18 |
DisclosureSEC source: 0001127602-17-013485 · form4.xml · nonDerivative · entry 2 Schomburger Jeffrey K · CIK 0001630117 · Global Sales Officer, CBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,227.55 F1 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. Read SEC document |
| April 03, 2017 Filed Apr 3, 2017 16:49 UTC |
Schomburger Jeffrey KGlobal Sales Officer, CBD
|
Tax withholdingCommon Stock | 497 | $90.09 | $44,772.25 |
DisclosureSEC source: 0001127602-17-013485 · form4.xml · nonDerivative · entry 1 Schomburger Jeffrey K · CIK 0001630117 · Global Sales Officer, CBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,735.55 F1 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 15:17 UTC |
MCNERNEY W JAMES JRDirector
|
GrantCommon Stock | 385 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-011864 · form4.xml · nonDerivative · entry 1 MCNERNEY W JAMES JR · CIK 0001182055 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,153.736 F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 15:19 UTC |
BLAKE FRANCIS SDirector
|
GrantCommon Stock | 248 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-011866 · form4.xml · nonDerivative · entry 1 BLAKE FRANCIS S · CIK 0001194702 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,254.172 F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 15:20 UTC |
LUNDGREN TERRY JDirector
|
GrantCommon Stock | 248 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-011867 · form4.xml · nonDerivative · entry 1 LUNDGREN TERRY J · CIK 0001184471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,929.212 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 15:22 UTC |
Braly Angela FDirector
|
GrantCommon Stock | 289 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-011869 · form4.xml · nonDerivative · entry 1 Braly Angela F · CIK 0001321458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,074.0018 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 15:23 UTC |
COOK SCOTT DDirector
|
GrantCommon Stock | 289 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-011870 · form4.xml · nonDerivative · entry 1 COOK SCOTT D · CIK 0000938861 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,498.736 F1 · price: Common Stock awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 15:24 UTC |
CHENAULT KENNETH IDirector
|
GrantCommon Stock | 248 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-011871 · form4.xml · nonDerivative · entry 1 CHENAULT KENNETH I · CIK 0001180524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,084.276 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2014 Stock and Incentive Compensation Plan F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:20 UTC |
Abdelfattah Mohamed Samir AbdelrazekPresident - IMEA SMO
|
GrantStock Option (Right to Buy) · Derivative | 35,581 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-17-009332 · form4.xml · derivative · entry 4 Abdelfattah Mohamed Samir Abdelrazek · CIK 0001613194 · President - IMEA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,581 Underlying: Common Stock · 35,581 shares Expires 2027-02-26 Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:20 UTC |
Abdelfattah Mohamed Samir AbdelrazekPresident - IMEA SMO
|
GrantCommon Stock | 4,173 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009332 · form4.xml · nonDerivative · entry 2 Abdelfattah Mohamed Samir Abdelrazek · CIK 0001613194 · President - IMEA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,125.4839 F3 · price: Restricted Stock Units awarded pursuant to issuer's 2014 Stock and Incentive Compensation Plan. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:20 UTC |
Abdelfattah Mohamed Samir AbdelrazekPresident - IMEA SMO
|
SaleCommon Stock | 1,876 | $91.25 | $171,176.37 |
DisclosureSEC source: 0001127602-17-009332 · form4.xml · nonDerivative · entry 1 Abdelfattah Mohamed Samir Abdelrazek · CIK 0001613194 · President - IMEA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,952.4839 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · price: Weighted average price of the shares sold. The price range was $91.2433 to $91.25. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:21 UTC |
Pritchard Marc S.Chief Brand Officer
|
GrantStock Option (Right to Buy) · Derivative | 110,019 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-17-009334 · form4.xml · derivative · entry 8 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,019 Underlying: Common Stock · 110,019 shares Expires 2027-02-26 Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:21 UTC |
Pritchard Marc S.Chief Brand Officer
|
SaleCommon Stock | 4,447 | $91.19 | $405,525.93 |
DisclosureSEC source: 0001127602-17-009334 · form4.xml · nonDerivative · entry 1 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,022.5813 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · price: Weighted average price of the shares sold. The price range was $91.187 to $91.197. Full information regarding the number of shares sold at each separate price available upon request. F3 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:22 UTC |
Schomburger Jeffrey KGlobal Sales Officer, CBD
|
GrantStock Option (Right to Buy) · Derivative | 102,295 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-17-009335 · form4.xml · derivative · entry 4 Schomburger Jeffrey K · CIK 0001630117 · Global Sales Officer, CBD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,295 Underlying: Common Stock · 102,295 shares Expires 2027-02-26 Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:23 UTC |
Moeller Jon RChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 20,857 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-17-009338 · form4.xml · derivative · entry 13 Moeller Jon R · CIK 0001450613 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 20,857 Underlying: Common Stock · 20,857 shares Expires 2027-02-26 Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:23 UTC |
Moeller Jon RChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 190,034 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-17-009338 · form4.xml · derivative · entry 12 Moeller Jon R · CIK 0001450613 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,034 Underlying: Common Stock · 190,034 shares Expires 2027-02-26 Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:23 UTC |
Moeller Jon RChief Financial Officer
|
GrantCommon Stock | 816 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009338 · form4.xml · nonDerivative · entry 5 Moeller Jon R · CIK 0001450613 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 9,538.448 F3 · price: Restricted Stock Units awarded pursuant to issuer's 2014 Stock and Incentive Compensation Plan. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:23 UTC |
Moeller Jon RChief Financial Officer
|
GrantCommon Stock | 7,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009338 · form4.xml · nonDerivative · entry 4 Moeller Jon R · CIK 0001450613 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,837.726 F3 · price: Restricted Stock Units awarded pursuant to issuer's 2014 Stock and Incentive Compensation Plan. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:23 UTC |
Moeller Jon RChief Financial Officer
|
SaleCommon Stock | 498 | $91.34 | $45,488.91 |
DisclosureSEC source: 0001127602-17-009338 · form4.xml · nonDerivative · entry 3 Moeller Jon R · CIK 0001450613 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 8,722.448 F2 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:23 UTC |
Moeller Jon RChief Financial Officer
|
SaleCommon Stock | 2,913 | $91.19 | $265,627.73 |
DisclosureSEC source: 0001127602-17-009338 · form4.xml · nonDerivative · entry 2 Moeller Jon R · CIK 0001450613 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,408.726 F2 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:24 UTC |
Biegger Mark FChief Human Resources Officer
|
GrantStock Option (Right to Buy) · Derivative | 113,062 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-17-009343 · form4.xml · derivative · entry 5 Biegger Mark F · CIK 0001557671 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,062 Underlying: Common Stock · 113,062 shares Expires 2027-02-26 Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:26 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
GrantStock Option (Right to Buy) · Derivative | 67,299 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-17-009347 · form4.xml · derivative · entry 6 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,299 Underlying: Common Stock · 67,299 shares Expires 2027-02-26 Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:26 UTC |
Majoras Deborah PChief Legal Officer & Secy
|
GrantCommon Stock | 7,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009347 · form4.xml · nonDerivative · entry 1 Majoras Deborah P · CIK 0001483177 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,273.461 F1 · price: Restricted Stock Units awarded pursuant to issuer's 2014 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:27 UTC |
Skoufalos IoannisGlobal Product Supply Officer
|
GrantStock Option (Right to Buy) · Derivative | 113,062 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-17-009350 · form4.xml · derivative · entry 4 Skoufalos Ioannis · CIK 0001525333 · Global Product Supply Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,062 Underlying: Common Stock · 113,062 shares Expires 2027-02-26 Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:27 UTC |
Skoufalos IoannisGlobal Product Supply Officer
|
SaleCommon Stock | 1,736 | $91.24 | $158,396.63 |
DisclosureSEC source: 0001127602-17-009350 · form4.xml · nonDerivative · entry 1 Skoufalos Ioannis · CIK 0001525333 · Global Product Supply Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,196.6191 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · price: Weighted average price of the shares sold. The price range was $91.24 to $91.2433. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:28 UTC |
Suranjan MagesvaranPresident - Asia Pacific SMO
|
GrantStock Option (Right to Buy) · Derivative | 94,289 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-17-009351 · form4.xml · derivative · entry 4 Magesvaran Suranjan · CIK 0001657274 · President - Asia Pacific SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,289 Underlying: Common Stock · 94,289 shares Expires 2027-02-26 Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:30 UTC |
Posada Juan FernandoPresident - LA SMO
|
GrantStock Option (Right to Buy) · Derivative | 94,289 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-17-009354 · form4.xml · derivative · entry 7 Posada Juan Fernando · CIK 0001653283 · President - LA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,289 Underlying: Common Stock · 94,289 shares Expires 2027-02-26 Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:30 UTC |
Posada Juan FernandoPresident - LA SMO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,872 | $0.00 Strike: $66.18 | $0.00 |
DisclosureSEC source: 0001127602-17-009354 · form4.xml · derivative · entry 6 Posada Juan Fernando · CIK 0001653283 · President - LA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 1,872 shares Expires 2018-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:30 UTC |
Posada Juan FernandoPresident - LA SMO
|
SaleCommon Stock | 1,872 | $90.94 | $170,231.82 |
DisclosureSEC source: 0001127602-17-009354 · form4.xml · nonDerivative · entry 2 Posada Juan Fernando · CIK 0001653283 · President - LA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,988.5041 F1 · price: Weighted average price of the shares sold. The price range was $90.9334 to $90.94. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:30 UTC |
Posada Juan FernandoPresident - LA SMO
|
Exercise / conversionCommon Stock | 1,872 | $66.18 | $123,888.96 |
DisclosureSEC source: 0001127602-17-009354 · form4.xml · nonDerivative · entry 1 Posada Juan Fernando · CIK 0001653283 · President - LA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,860.5041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:29 UTC |
Matthew PricePresident - Greater China SMO
|
GrantStock Option (Right to Buy) · Derivative | 60,043 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-17-009352 · form4.xml · derivative · entry 4 Matthew Price · CIK 0001630203 · President - Greater China SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,043 Underlying: Common Stock · 60,043 shares Expires 2027-02-26 Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:29 UTC |
Matthew PricePresident - Greater China SMO
|
GrantCommon Stock | 2,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009352 · form4.xml · nonDerivative · entry 2 Matthew Price · CIK 0001630203 · President - Greater China SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,477 F3 · price: Restricted Stock Units awarded pursuant to issuer's 2014 Stock and Incentive Compensation Plan. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:29 UTC |
Matthew PricePresident - Greater China SMO
|
SaleCommon Stock | 3,833 | $91.24 | $349,706.05 |
DisclosureSEC source: 0001127602-17-009352 · form4.xml · nonDerivative · entry 1 Matthew Price · CIK 0001630203 · President - Greater China SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,129 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · price: Weighted average price of the shares sold. The price range was $91.231 to $91.241. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:31 UTC |
Taylor David SDirector · President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 280,899 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-17-009355 · form4.xml · derivative · entry 4 Taylor David S · CIK 0001505989 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,899 Underlying: Common Stock · 280,899 shares Expires 2027-02-26 Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:31 UTC |
Taylor David SDirector · President & CEO
|
GrantCommon Stock | 32,942 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009355 · form4.xml · nonDerivative · entry 1 Taylor David S · CIK 0001505989 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,011.5874 F1 · price: Restricted Stock Units awarded pursuant to issuer's 2014 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:33 UTC |
TASTAD CAROLYN MGroup President - NA SMO
|
GrantStock Option (Right to Buy) · Derivative | 96,559 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-17-009358 · form4.xml · derivative · entry 7 TASTAD CAROLYN M · CIK 0001597938 · Group President - NA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,559 Underlying: Common Stock · 96,559 shares Expires 2027-02-26 Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:33 UTC |
TASTAD CAROLYN MGroup President - NA SMO
|
GrantCommon Stock | 3,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-009358 · form4.xml · nonDerivative · entry 2 TASTAD CAROLYN M · CIK 0001597938 · Group President - NA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,290.092 F3 · price: Restricted Stock Units awarded pursuant to issuer's 2014 Stock and Incentive Compensation Plan. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:33 UTC |
TASTAD CAROLYN MGroup President - NA SMO
|
SaleCommon Stock | 965 | $91.20 | $88,011.47 |
DisclosureSEC source: 0001127602-17-009358 · form4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Group President - NA SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,515.092 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:34 UTC |
Coombe Gary APresident-Europe SMO
|
GrantStock Option (Right to Buy) · Derivative | 97,847 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-17-009360 · form4.xml · derivative · entry 4 Coombe Gary A · CIK 0001623622 · President-Europe SMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,847 Underlying: Common Stock · 97,847 shares Expires 2027-02-26 Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:35 UTC |
Louvet PatriceGroup President, Global Beauty
|
GrantStock Option (Right to Buy) · Derivative | 124,766 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-17-009362 · form4.xml · derivative · entry 4 Louvet Patrice · CIK 0001669213 · Group President, Global Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,766 Underlying: Common Stock · 124,766 shares Expires 2027-02-26 Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:35 UTC |
Louvet PatriceGroup President, Global Beauty
|
SaleCommon Stock | 2,088 | $91.24 | $190,516.01 |
DisclosureSEC source: 0001127602-17-009362 · form4.xml · nonDerivative · entry 1 Louvet Patrice · CIK 0001669213 · Group President, Global Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,750.006 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · price: Weighted average price of the shares sold. The price range was $91.241 to $91.251. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:36 UTC |
FergusonMchugh MaryLynnGroup President Global Family
|
GrantStock Option (Right to Buy) · Derivative | 70,693 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-17-009364 · form4.xml · derivative · entry 7 FergusonMchugh MaryLynn · CIK 0001613133 · Group President Global Family 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,693 Underlying: Common Stock · 70,693 shares Expires 2027-02-26 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.